Feasibility, acceptability and preferences for intraperitoneal chemotherapy with paclitaxel and cisplatin after optimal debulking surgery for ovarian and related cancers: an ANZGOG study

OBJECTIVE: Intraperitoneal (IP) chemotherapy in women with optimally debulked stage III ovarian cancer has been reported to prolong overall survival, but has not been widely adopted due to concerns about its toxicity, inconvenience and acceptability to patients. The purposes of this study were to de...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Blinman, Prunella, Gainford, Corona, Donoghoe, Mark, Martyn, Julie, Blomfield, Penny, Grant, Peter, Kichenadasse, Ganessan, Vaughan, Michelle, Brand, Alison, Shannon, Catherine, Gebski, Val, Stockler, Martin, Friedlander, Michael
Format: Artigo
Langue:Inglês
Publié: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2013
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3805917/
https://ncbi.nlm.nih.gov/pubmed/24167672
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3802/jgo.2013.24.4.359
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires